Currently, while DUR Board meetings are being held via Microsoft Teams, to sign up for public comment, send an email to email@example.com on the Friday before the Tuesday meeting. Please include your name, title, company or affiliation and the drug/drug class that you want to speak about. Click here for meeting details.
For In-Person Meetings:
Upon your arrival at the Drug Utilization Review Board (DURB) meeting, there will be two sheets to sign. The first sheet is the general attendance sheet and the second sheet is for public comment.
The public comment sheet requires the speaker's name, company/affiliation and drug product. During the meeting, when the product is to be discussed, your name will be called, and you will be allotted 3 minutes to speak.